Ebselen inhibits QSOX1 enzymatic activity and suppresses invasion of pancreatic and renal cancer cell lines
about
Mass spectrometry-based secretome analysis of non-small cell lung cancer cell lines.Ebselen Is a Potential Anti-Osteoporosis Agent by Suppressing Receptor Activator of Nuclear Factor Kappa-B Ligand-Induced Osteoclast Differentiation In vitro and Lipopolysaccharide-Induced Inflammatory Bone Destruction In vivoEbselen impairs cellular oxidative state and induces endoplasmic reticulum stress and activation of crucial mitogen-activated protein kinases in pancreatic tumour AR42J cells.Reduced QSOX1 enhances radioresistance in nasopharyngeal carcinoma.QSOX1 expression is associated with aggressive tumor features and reduced survival in breast carcinomas.Current Challenges and Opportunities in Treating Glioblastoma.
P2860
Ebselen inhibits QSOX1 enzymatic activity and suppresses invasion of pancreatic and renal cancer cell lines
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Ebselen inhibits QSOX1 enzymat ...... ic and renal cancer cell lines
@ast
Ebselen inhibits QSOX1 enzymat ...... ic and renal cancer cell lines
@en
type
label
Ebselen inhibits QSOX1 enzymat ...... ic and renal cancer cell lines
@ast
Ebselen inhibits QSOX1 enzymat ...... ic and renal cancer cell lines
@en
prefLabel
Ebselen inhibits QSOX1 enzymat ...... ic and renal cancer cell lines
@ast
Ebselen inhibits QSOX1 enzymat ...... ic and renal cancer cell lines
@en
P2093
P2860
P356
P1433
P1476
Ebselen inhibits QSOX1 enzymat ...... ic and renal cancer cell lines
@en
P2093
Benjamin A Katchman
Chad R Borges
Chen-Ting Ma
Douglas F Lake
Douglas O Faigel
Eduard A Sergienko
Joachim L Petit
Nathalie Meurice
Paul D Hanavan
P2860
P304
18418-18428
P356
10.18632/ONCOTARGET.4099
P407
P50
P577
2015-06-01T00:00:00Z